Aaron John Christian Andersen

Aaron John Christian Andersen

Auto-generated profile, based on publicly available information

Aaron John Christian Andersen

Department of Biotechnology and Biomedicine, Technical University of Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2016 in Journal of Natural Products
Verified
Journal Article
Closed access
SRSilas Anselm Rasmussen
Silas Anselm Rasmussen
AAAaron John Christian Andersen
Aaron John Christian Andersen
NANikolaj Gedsted Andersen
Nikolaj Gedsted Andersen
KNKristian Fog Nielsen
Kristian Fog Nielsen
PHPer Juel Hansen
Per Juel Hansen
TLThomas Ostenfeld Larsen
Thomas Ostenfeld Larsen

Verified
Journal Article
Open access
PDF file
IHIda Kristine Østnes Hansen
Ida Kristine Østnes Hansen
TLTomas Lövdahl
Tomas Lövdahl
DSDanijela Simonovic
Danijela Simonovic
KHKine Østnes Hansen
Kine Østnes Hansen
AAAaron J. C. Andersen
Aaron J. C. Andersen
THTor Haug
Tor Haug
Turgencin A, a potent antimicrobial peptide isolated from the Arctic sea squirt Synoicum turgens, consists of 36 amino acid residues and three disulfide bridges, making it challenging to synthesize. The aim of the present study was to develop a truncated peptide with an antimicrobial drug lead potential based on turgencin A. The experiments consisted of: (1) sequence analysis and prediction of antimicrobial potential of truncated 10-mer sequences; (2) synthesis and antimicrobial screening of a lead peptide devoid of the cysteine residues; (3) optimization of in vitro antimicrobial activity of the lead peptide using an amino acid replacement strategy; and (4) screening the synthesized peptides for cytotoxic activities. In silico analysis of turgencin A using various prediction software indicated an internal, cationic 10-mer sequence to be putatively antimicrobial. The synthesized truncated lead peptide displayed weak antimicrobial activity. However, by following a systematic amino acid replacement strategy, a modified peptide was developed that retained the potency of the original peptide. The optimized peptide StAMP-9 displayed bactericidal activity, with minimal inhibitory concentrations of 7.8 µg/mL against Staphylococcus aureus and 3.9 µg/mL against Escherichia coli, and no cytotoxic effects against mammalian cells. Preliminary experiments indicate the bacterial membranes as immediate and primary targets.

24 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JHJONATHAN HIRA
JONATHAN HIRA
DWDeanna Wolfson
Deanna Wolfson
AAAaron John Christian Andersen
Aaron John Christian Andersen
THTor Haug
Tor Haug
KSKlara Stensvåg
Klara Stensvåg
Red spherule cells (RSCs) are considered one of the prime immune cells of sea urchins, but their detailed biological role during immune responses is not well elucidated. Lack of pure populations accounts for one of the major challenges of studying these cells. In this study, we have demonstrated that live RSCs exhibit strong, multi-colour autofluorescence distinct from other coelomocytes, and with the help of fluorescence-activated cell sorting (FACS), a pure population of live RSCs was successfully separated from other coelomocytes in the green sea urchin, Strongylocentrotus droebachiensis. This newly developed RSCs isolation method has allowed profiling of the naphthoquinone content in these cells. With the use of ultra high-performance liquid chromatography, UV absorption spectra, and high-resolution tandem mass spectrometry, it was possible to identify sulphated derivatives of spinochrome C, D, E and spinochrome dimers, which suggests that the RSCs may play an important biological role in the biogenesis of naphthoquinone compounds and regulating their bioactivity.

12 January 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
IHIda Kristine Østnes Hansen
Ida Kristine Østnes Hansen
JIJohan Isaksson
Johan Isaksson
APAaron Poth
Aaron Poth
KHKine Østnes Hansen
Kine Østnes Hansen
AAAaron J. C. Andersen
Aaron J. C. Andersen
THTor Haug
Tor Haug
This study reports the isolation of two novel cysteine-rich antibacterial peptides, turgencin A and turgencin B, along with their oxidized derivatives, from the Arctic marine colonial ascidian Synoicum turgens. The peptides are post-translationally modified, containing six cysteines with an unusual disulfide connectivity of Cys1-Cys6, Cys2-Cys5, and Cys3-Cys4 and an amidated C-terminus. Furthermore, the peptides contain methionine residues resulting in the isolation of peptides with different degrees of oxidation. The most potent peptide, turgencin AMox1 with one oxidized methionine, displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria with a minimum inhibitory concentration (MIC) as low as 0.4 µM against selected bacterial strains. In addition, the peptide inhibited the growth of the melanoma cancer cell line A2058 (IC50 = 1.4 µM) and the human fibroblast cell line MRC-5 (IC50 = 4.8 µM). The results from this study show that natural peptides isolated from marine tunicates have the potential to be promising drug leads.

8 January 2024 in The ISME Journal
Verified
Journal Article
Open access
PDF file
MHMorten L Hansen
Morten L Hansen
ZDZsófia Dénes
Zsófia Dénes
SJScott A Jarmusch
Scott A Jarmusch
MWMario Wibowo
Mario Wibowo
CLCarlos N Lozano-Andrade
Carlos N Lozano-Andrade
LJLars Jelsbak
Lars Jelsbak
The role of antagonistic secondary metabolites produced by Pseudomonas protegens in suppression of soil-borne phytopathogens has been clearly documented. However, their contribution to the ability of P. protegens to establish in soil and rhizosphere microbiomes remains less clear. Here, we use a four-species synthetic community (SynCom) in which individual members are sensitive towards key P. protegens antimicrobial metabolites (DAPG, pyoluteorin, and orfamide A) to determine how antibiotic production contributes to P. protegens community invasion and to identify community traits that counteract the antimicrobial effects. We show that P. protegens readily invades and alters the SynCom composition over time, and that P. protegens establishment requires production of DAPG and pyoluteorin. An orfamide A-deficient mutant of P. protegens invades the community as efficiently as wildtype, and both cause similar perturbations to community composition. Here, we identify the microbial interactions underlying the absence of an orfamide A mediated impact on the otherwise antibiotic-sensitive SynCom member, and show that the cyclic lipopeptide is inactivated and degraded by the combined action of Rhodococcus globerulus D757 and Stenotrophomonas indicatrix D763. Altogether, the demonstration that the synthetic community constrains P. protegens invasion by detoxifying its antibiotics may provide a mechanistic explanation to inconsistencies in biocontrol effectiveness in situ.